Gipharma LEUKOKIT® supports Imaging in Infection and Inflammation training
Press Release | Gipharma Srl
JUNE 11, 2015
Saluggia, Italy: – Injectables small volume liquids, lyophilized parenterals and radiopharmaceuticals specialist Gipharma will be a leading presence at the European School of Nuclear Medicine (ESNM) Practical Learning Course on Imaging in Infection & Inflammation later this month.
The course, to be hosted in Vienna, will include a specific session on labeling of white blood cells (leukocytes) with a procedure based on Gipharma’s widely used LEUKOKIT®, in accordance to Consensus Protocol ISORBE.
Gipharma Commercial Director Andrea Confetti will represent the company in Vienna.
Simple purification and labeling
LEUKOKIT® is a simple device for easy sterile purification and labeling of autologous leukocytes with radioactive isotopes.
“I am looking forward to learn personally how the features and the benefits of our LEUKOKIT® are perceived during its practical use in Nuclear Medicine procedures” said Mr. Confetti.
“This is a precious opportunity to gather valuable in-field experience and to monitor how we have been supporting the requirements of end users in Nuclear Medicine centers”, he added.
Gipharma Srl operates from Saluggia, northwest Italy, as a pharmaceutical contract manufacturing organization (CMO) for small volume injectable liquids and freeze-dried powders (aseptic and terminally sterilized processes). The company typically handles small/medium-sized product batches ranging from 5.000 to 14.000 vials.
Gipharma specializes in oxygen-sensitive products such as radiopharmaceutical cold kits, which it supplies to all leading imaging players in Europe. It also provides analytical assays along with sterility and endotoxin testing of drug products. It can release drug product and investigational medicinal product (IMP) batches for Europe. Its also provides support services in PET radiopharmaceutical manufacturing and testing.
Gipharma is fully owned by Advanced Accelerator Applications SA, an international specialist in Molecular Nuclear Medicine.
The Italian Superior Health Institute (ISS) has certified Gipharma’s Quality System according to annex V of European Directive 93/42/EEC.
More information at: www.gipharma.com
LEUKOKIT® is a single use kit which contains all necessary materials apart from the radiopharmaceutical agent to carry out separation of leukocytes from blood and label them before re-injection.
LEUKOKIT® has been classified as Medical Device, Class 2b, with a CE Mark from the Italian Superior Health Institute (ISS) as Notified Body n°0373 (Certificate n. 043 CTP 305 of 15/04/2008, according to Annex III of European Directive 93/42/CEE).
More information at: www.leukokit.com
Gipharma is s a member of EANM, European Association of Nuclear Medicine, the umbrella organisation for radiopharmaceutical medicine in Europe. EANM aims to advance science and education in nuclear medicine for the benefit of public health as well as promoting and coordinating discussion and exchange of ideas and results relating to the diagnosis, treatment, research and prevention of diseases through the use of unsealed radioactive substances and the properties of stable nuclides in medicine.
In 2003, it EANM founded the European School of Nuclear Medicine (ESNM) tasked with hosting a wide range of theoretical and practical learning courses.
ESNM offers its Education programs both at the EANM Annual Congress and at the EANM Educational Facility in Vienna.
Dr. Andrea Confetti, Commercial Director, Gipharma Srl, Italy
Tel: +39 0161 487 141
Click on Gipharma LEUKOKIT® supports Imaging in Infection and Inflammation training for more information.
Click on Gipharma to contact the company directly.